Peripheral Nerve Stimulation and Peripheral Nerve Field Stimulation
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - North Carolina policy alerts
Know when Blue Cross Blue Shield - North Carolina releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs Medicare (and supported third-party Medicare plans) coverage criteria for peripheral nerve stimulation (PNS) and peripheral nerve field stimulation (PNFS) for chronic pain, defining indications, required documentation, and exclusions for providers and claims reviewers.
Converted from a Summary to a Medical Policy based on CY 2024 CMS Final Rule; minor grammatical revisions made.
Removed codes billed for Vagus Nerve Stimulator treatment and updated references during the January 9, 2026 annual review.
Coverage Criteria for PNS/PNFS
inv-01: PNS Coverage (Initial)
Covered when ALL of the following are met:
All 7 conditions required prior to permanent implantation.
Peripheral nerve field stimulation (PNFS) is not covered. Current peer-reviewed data are insufficient to support the medical necessity of PNFS for any condition, and therefore PNFS will not be approved for coverage under this policy. Requests for peripheral nerve stimulation (PNS) remain subject to the policy’s coverage criteria; however, PNS is not covered for several specified diagnoses (see exclusions).
When considering PNS requests, providers must follow the documented coverage criteria for PNS including required documentation of failed conservative therapies, minimum duration of chronic severe pain, psychological screening, and a successful stimulation trial prior to permanent implantation. Requests that do not meet those PNS criteria — or that are for diagnoses explicitly excluded — will be considered not reasonable and necessary.
Requests for PNFS for any condition are considered not reasonable and necessary and will not be covered because the current peer-reviewed evidence is inadequate to demonstrate improved health outcomes with PNFS.
Requests for PNS for the diagnoses listed in the exclusions (including but not limited to fibromyalgia, phantom limb pain, diffuse polyneuropathy, nociceptive trunk or lower back pain, angina pectoris, occipital neuralgia, trigeminal nerve–related facial pain, complex regional pain syndromes, peripheral nerve injury, post-surgical scar pain, nerve entrapment, painful mononeuropathy, and painful amputation neuromas) are also considered not reasonable and necessary and will be denied.
Applicable Procedure and Billing Codes
Provider Requirements and Prior Authorization
Prior approval required; inclusion of codes doesn't guarantee payment
Codes listed in the policy require prior approval by the Plan; inclusion of a code in the policy does not guarantee reimbursement and the Plan may request medical records to determine medical necessity.
Conservative treatment prerequisite — document failed trials
Prior conservative treatments must have been attempted and failed before PNS is considered.
- Examples of less invasive treatments include attempts to cure the underlying condition, physical therapy, braces, and medications such as pregabalin (Lyrica) or gabapentin (Neurontin).
- Documentation of failure of these treatments is required prior to PNS.
Required clinical documentation for medical necessity
Provide medical records that demonstrate the required clinical elements for PNS coverage prior to permanent implantation.
- Document chronic and severe pain for at least 3 months.
- Document failure of less invasive treatment modalities (e.g., physical therapy, braces, pregabalin or gabapentin).
- Document absence of surgical contraindications (e.g., infection, medical risks).
- Document appropriate patient education, informed consent, no active substance abuse, and formal psychological screening by a mental health professional.
- Document a successful stimulation trial with ≥50% reduction in pain intensity prior to permanent implantation.
- Be prepared to supply medical records and any supporting letters when requested by the Plan; letters alone are insufficient unless they contain all required information.
Denial triggers — unmet criteria or excluded diagnoses
Claims will be denied when required coverage criteria or documentation are not met.
- Denial triggers include failure to meet any of the PNS coverage criteria (e.g., <3 months of documented chronic severe pain, lack of documented failed conservative therapies, absence of a successful trial with ≥50% pain reduction).
- Requests for PNFS for any condition, and PNS for excluded diagnoses (e.g., fibromyalgia, phantom limb pain, diffuse polyneuropathy, nociceptive trunk/lower back pain, angina pectoris, occipital neuralgia, trigeminal nerve conditions, CRPS types 1 and 2, post-surgical neuropathic pain, etc.) will be denied as not reasonable and necessary.
Background and Clinical Context
Peripheral nerve stimulation (PNS) involves placement of a lead near the anatomical location of a peripheral nerve, by open or percutaneous approach, to lessen chronic pain. Leads may be connected to an external pulse generator temporarily for a trial or to an implanted generator for long-term therapy. Peripheral nerve field stimulation (PNFS) uses needle electrodes inserted through the skin to stimulate a subcutaneous field and is commonly performed in office or outpatient settings.
The clinical rationale for PNS is to provide targeted neuromodulation of a peripheral nerve distribution for patients with chronic, severe pain who have failed less invasive therapies. A formal stimulation trial is the primary predictor of benefit: this policy requires documentation of a successful trial (defined in the coverage criteria) before permanent implantation. By contrast, PNFS lacks sufficient peer-reviewed evidence of improved health outcomes and therefore is excluded from coverage.
Key Definitions
Conservative Treatment Requirements Before PNS
Timing and Frequency Limits
Imaging and Procedural Guidance
Imaging for PNS/PNFS implantation not specified in policy
No explicit imaging requirement is specified in the policy for PNS/PNFS implantation; standard practice may include imaging to localize peripheral nerves for lead placement, but the policy notes imaging requirements as not specified.
- Policy: imaging requirement for implantation is not specified.
- Special note: implantation beyond a one-month trial requires documentation if therapeutic benefit determination takes longer than one month.
Services Not Covered
PNFS is not covered for any condition because current peer-reviewed data are insufficient to establish medical necessity.
PNS is not covered for the following diagnoses and clinical situations: fibromyalgia; phantom limb pain; diffuse polyneuropathy; nociceptive pain of the trunk or lower back; angina pectoris; occipital neuralgia; post-surgical neuropathic pain; cervicogenic headaches; treatment-resistant migraine; trigeminal nerve–related facial pain; complex regional pain syndrome (types 1 and 2); peripheral nerve injury; post-surgical scar pain; nerve entrapment; painful mononeuropathy; and painful amputation neuromas. Requests for these indications are considered not reasonable and necessary and will be denied.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.